ArticleScientific reports2025
PKA prevents the resection of DNA double-strand breaks and favours nonhomologous end-joining.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genome rearrangement is a hallmark of cancer and ageing. DNA double-strand breaks (DSBs) are highly toxic lesions that can generate genome rearrangements. Several pathways compete for DSB repair, and selection of the appropriate repair process is critical for genetic stability. DSB repair acts according to two steps: (1) the choice between nonhomologous end-joining (NHEJ) and the resection of DNA ends, generating single-stranded DNA (ssDNA) and (2) on generated ssDNA, homologous recombination (HR) and sub-processes. Here, we show that 53BP1, which plays a prime role in the first step by protecting against resection and fostering NHEJ, physically interacts with the catalytic subunits of cAMP-dependent protein kinase A (PKAcs). PKA favours the recruitment of 53BP1 at DNA damage sites and consistently prevents resection, favouring NHEJ. Inhibition of PKA stimulated resection and concurrently reduced NHEJ. Conversely, the activation of PKA with 8-Bromo-cAMP stimulated NHEJ and reduced HR. These data provide new avenues for potential anticancer strategies. More generally, these findings underscore the high complexity of the regulation of DSB repair, identifying PKA as a novel participant in the DNA damage response that acts in the DSB repair process, which may be essential for maintaining genome integrity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.